Nautilus Biotechnology, Inc. (NAUT) Ownership

$0.71

south_east
-$0.03 (-3.92%)
Day's range
$0.7
Day's range
$0.74

Nautilus Biotechnology, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
AH CAPITAL MANAGEMENT, L.L.C. 02/12/2025 17.65 M $29.66 M   0.00% 14.07%
PERCEPTIVE ADVISORS LLC 02/14/2025 12.59 M $21.16 M   0.00% 10.04%
CERCANO MANAGEMENT LLC 02/14/2025 7.17 M $12.05 M   0.00% 5.72%
MADRONA VENTURE GROUP, LLC 02/14/2025 6.02 M $10.12 M   0.00% 4.80%
BLACKROCK, INC. 02/07/2025 3.07 M $5.16 M   -13.93% 2.45%
VANGUARD GROUP INC 02/11/2025 2.78 M $4.67 M   0.44% 2.21%
COMPREHENSIVE FINANCIAL MANAGEMENT LLC 02/14/2025 2.21 M $3.71 M   0.00% 1.76%
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC 02/14/2025 1.76 M $2.96 M   -12.05% 1.40%
AMAZON COM INC 02/07/2025 1.46 M $2.45 M   0.00% 1.16%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 1.14 M $1.92 M   0.62% 0.91%
STATE STREET CORP 02/14/2025 930,531 $1.56 M   -0.26% 0.74%
DIMENSIONAL FUND ADVISORS LP 02/13/2025 770,353 $1.29 M   11.32% 0.61%
TIKVAH MANAGEMENT LLC 02/13/2025 726,895 $1.22 M   0.00% 0.58%
CLARIUS GROUP, LLC 01/16/2025 636,532 $1.07 M   0.00% 0.51%
ARCHPOINT INVESTORS 02/13/2025 606,133 $1.02 M   -1.32% 0.48%
NORTHERN TRUST CORP 02/14/2025 474,821 $797,699   -6.44% 0.38%
MORGAN STANLEY 02/14/2025 393,606 $661,258   -1.72% 0.31%
WEXFORD CAPITAL LP 02/14/2025 325,239 $546,402   42.43% 0.26%
SENTINEL TRUST CO LBA 02/05/2025 255,000 $428,000   -19.05% 0.20%
ALYESKA INVESTMENT GROUP, L.P. 02/14/2025 253,468 $425,826   -42.53% 0.20%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 250,221 $420,371   61.75% 0.20%
CITADEL ADVISORS LLC 02/14/2025 220,220 $369,970   177.57% 0.18%
HILLMAN CO 01/21/2025 200,000 $336,000   0.00% 0.16%
GOLDMAN SACHS GROUP INC 02/11/2025 195,695 $328,768   20.56% 0.16%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 193,591 $325,234   0.00% 0.15%
JPMORGAN CHASE & CO 02/12/2025 145,937 $245,173   309.90% 0.12%
BARCLAYS PLC 02/13/2025 125,204 $210,000   17.92% 0.10%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 115,231 $193,588   -16.19% 0.09%
JANE STREET GROUP, LLC 02/14/2025 108,545 $182,356   188.06% 0.09%
BANK OF NEW YORK MELLON CORP 02/04/2025 106,697 $179,251   0.00% 0.09%
RHUMBLINE ADVISERS 01/30/2025 73,383 $123,275   3.52% 0.06%
HSBC HOLDINGS PLC 02/14/2025 55,184 $92,157   182.50% 0.04%
BANK OF AMERICA CORP /DE/ 02/14/2025 49,419 $83,024   37.06% 0.04%
UBS GROUP AG 02/14/2025 47,230 $79,346   70.01% 0.04%
CI PRIVATE WEALTH, LLC 02/10/2025 45,350 $76,188   0.00% 0.04%
CITIGROUP INC 02/12/2025 40,572 $68,160   4.08% 0.03%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 39,004 $65,527   100.00% 0.03%
MILLENNIUM MANAGEMENT LLC 02/14/2025 37,704 $63,343   100.00% 0.03%
SIGNATUREFD, LLC 02/10/2025 37,313 $62,686   0.00% 0.03%
VANGUARD CAPITAL WEALTH ADVISORS 02/18/2025 31,500 $52,920   -10.00% 0.03%
BADGLEY PHELPS WEALTH MANAGERS, LLC 02/11/2025 30,000 $50,400   0.00% 0.02%
WELLS FARGO & COMPANY/MN 02/13/2025 28,896 $48,545   11.00% 0.02%
PALUMBO WEALTH MANAGEMENT LLC 01/30/2025 28,475 $47,838   45.38% 0.02%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 02/14/2025 27,878 $46,835   4.56% 0.02%
SG AMERICAS SECURITIES, LLC 01/17/2025 27,483 $46,000   56.34% 0.02%
SQUAREPOINT OPS LLC 02/14/2025 26,324 $44,224   100.00% 0.02%
COREBRIDGE FINANCIAL, INC. 02/11/2025 24,222 $40,693   -7.02% 0.02%
LAKE STREET ADVISORS GROUP, LLC 02/04/2025 22,762 $38,240   0.00% 0.02%
DEUTSCHE BANK AG\ 02/14/2025 22,369 $37,580   0.00% 0.02%
ALLIANCEBERNSTEIN L.P. 02/12/2025 21,460 $36,053   0.00% 0.02%

Nautilus Biotechnology, Inc. institutional Ownership - FAQ's

During the previous two years, 93 institutional investors and hedge funds held shares of Nautilus Biotechnology, Inc.. The most heavily invested institutionals were:

Elser Financial Planning, Inc: 0

Nelson, Van Denburg & Campbell Wealth Management Group, LLC: 0

Northstar Advisory Group, LLC: 0

Ronald Blue Trust, Inc.: 0

AH Capital Management, L.L.C.: 17.65 M

PERCEPTIVE ADVISORS LLC: 12.59 M

50.90% of Nautilus Biotechnology, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 84.51 M shares in the last 24 months. This purchase volume represents approximately $60.25 M in transactions.